We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

Scientists Develop Concept with Potential to Help Predict how Individuals may Respond to Drugs
News

Scientists Develop Concept with Potential to Help Predict how Individuals may Respond to Drugs

The method is expected to be synergistic with existing pharmacogenomic approaches.
Dalton Pharma Services Announces Completion of its GMP Oligonucleotide Manufacturing Facility
News

Dalton Pharma Services Announces Completion of its GMP Oligonucleotide Manufacturing Facility

Building on its 17 year history in oligonucleotide manufacture and analysis, Dalton can now use its expertise in synthesis and manufacturing of antisense oligonucleotides.
bmd Obtains FDA Approval for Four new FIDIS™ Diagnostic Kits for Autoimmune Diseases
News

bmd Obtains FDA Approval for Four new FIDIS™ Diagnostic Kits for Autoimmune Diseases

Approval of FIDIS Connective 10, Vasculitis, Celiac IgC and Celiac IgA will boost bmd's penetration of the North American market
Expanded Access Program for Rexin-G™ Provides Genetic Medicine to Cancer Patients
News

Expanded Access Program for Rexin-G™ Provides Genetic Medicine to Cancer Patients

The Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients.
Industry Leaders and Investors Explore Better Business Models for the 'New Diagnostics' at Bio 2006
News

Industry Leaders and Investors Explore Better Business Models for the 'New Diagnostics' at Bio 2006

Experts will debate business models to support the growing potential of molecular diagnostics during a kick-off panel at BIO 2006.
Third Wave and Mitsubishi Announce Japanese Joint Venture for Personalized Medicine
News

Third Wave and Mitsubishi Announce Japanese Joint Venture for Personalized Medicine

Third Wave will accelerate and expand the development of high-value clinical products for the Japanese molecular diagnostic market.
Plexxikon Advances First Oncology Development Candidate
News

Plexxikon Advances First Oncology Development Candidate

Preclinical data for oncogenic B-Raf inhibitor presented at American Association for Cancer Research Annual Meeting.
PerkinElmer and JMC Collaborate to Develop Molecular Diagnostics Screening Platforms
News

PerkinElmer and JMC Collaborate to Develop Molecular Diagnostics Screening Platforms

Partnership expected to advance capabilities in screening assays and discovery and validation of new biomarkers.
Upstream Completes Acquisition of Genetic Diagnostic Marker Company
News

Upstream Completes Acquisition of Genetic Diagnostic Marker Company

As a result of the transaction, Upstream Canada is now a wholly-owned subsidiary of the Company.
Shimadzu, Toppan and Third Wave Sign Agreement for Point-of-Care Instrument
News

Shimadzu, Toppan and Third Wave Sign Agreement for Point-of-Care Instrument

The instrument is designed to analyzing a patient's DNA for specific gene sequences.
Advertisement